Published in Infect Immun on July 01, 1985
Clinical microbiology of coryneform bacteria. Clin Microbiol Rev (1997) 8.40
Genomics of Actinobacteria: tracing the evolutionary history of an ancient phylum. Microbiol Mol Biol Rev (2007) 4.13
Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions. Clin Microbiol Rev (2002) 2.18
Role of rifampin against Propionibacterium acnes biofilm in vitro and in an experimental foreign-body infection model. Antimicrob Agents Chemother (2012) 2.02
Antibodies elicited by inactivated propionibacterium acnes-based vaccines exert protective immunity and attenuate the IL-8 production in human sebocytes: relevance to therapy for acne vulgaris. J Invest Dermatol (2008) 1.55
Pathogenesis of gram-positive bacterial endophthalmitis. Infect Immun (1999) 1.50
Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen. Clin Microbiol Rev (2014) 1.38
Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris. J Invest Dermatol (2009) 1.35
Direct visualization of Propionibacterium acnes in prostate tissue by multicolor fluorescent in situ hybridization assay. J Clin Microbiol (2007) 1.18
Prosthetic valve endocarditis due to Propionibacterium acnes. Interact Cardiovasc Thorac Surg (2016) 1.09
Propionibacterium acnes CAMP factor and host acid sphingomyelinase contribute to bacterial virulence: potential targets for inflammatory acne treatment. PLoS One (2011) 1.04
Aggressive management of an epidemic of chronic pseudophakic endophthalmitis: results and literature survey. Br J Ophthalmol (1994) 1.04
Chronic postoperative endophthalmitis: a review of clinical characteristics, microbiology, treatment strategies, and outcomes. Int J Inflam (2012) 0.98
Failure of Gram stain to detect Propionibacterium acnes in specimens from clinically significant infections. J Clin Microbiol (1996) 0.92
Propionibacterium acnes infection induces upregulation of inflammatory genes and cytokine secretion in prostate epithelial cells. BMC Microbiol (2010) 0.89
Deciphering the intracellular fate of Propionibacterium acnes in macrophages. Biomed Res Int (2013) 0.86
Management of Propionibacterium acnes infection after shoulder surgery. Curr Rev Musculoskelet Med (2015) 0.77
Current approach to postoperative endophthalmitis. Br J Ophthalmol (1997) 0.76
A Derivative of the Thiopeptide GE2270A Highly Selective against Propionibacterium acnes. Antimicrob Agents Chemother (2015) 0.76
Immunoproteomic Identification of In Vivo-Produced Propionibacterium acnes Proteins in a Rabbit Biofilm Infection Model. Clin Vaccine Immunol (2015) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia. J Exp Med (1966) 9.20
Myeloperoxidase-halide-hydrogen peroxide antibacterial system. J Bacteriol (1968) 7.67
The fate of bacteria within phagocytic cells. I. The degradation of isotopically labeled bacteria by polymorphonuclear leucocytes and macrophages. J Exp Med (1963) 5.96
Character of azurophil and specific granules purified from human polymorphonuclear leukocytes. Lab Invest (1974) 4.09
An overview of acne. J Invest Dermatol (1974) 3.20
Bactericidal activity of a superoxide anion-generating system. A model for the polymorphonuclear leukocyte. J Exp Med (1979) 3.19
Corynebacterium parvum: a synonym for Propionibacterium acnes? J Gen Microbiol (1974) 1.89
Processing of streptococcal cell walls by rat macrophages and human monocytes in vitro. Infect Immun (1977) 1.86
Resistance of O-acetylated gonococcal peptidoglycan to human peptidoglycan-degrading enzymes. Infect Immun (1983) 1.58
Strain-related differences in lysozyme sensitivity and extent of O-acetylation of gonococcal peptidoglycan. Infect Immun (1982) 1.48
Myeloperoxidase of human neutrophilic granulocytes as chlorinating enzyme. Eur J Biochem (1974) 1.44
Degradation of 14C-labeled streptococcal cell walls by egg white lysozyme and lysosomal enzymes. Infect Immun (1976) 1.36
Effect of leukocyte hydrolases on bacteria. I. Degradation of 14C-labeled Streptococcus and Staphylococcus by leukocyte lysates in vitro. J Infect Dis (1974) 1.27
Degradation of granuloma-inducing micro-organisms by macrophages. J Pathol (1970) 1.24
Complement activation in acne vulgaris: in vitro studies with Propionibacterium acnes and Propionibacterium granulosum. Infect Immun (1978) 1.16
Characterization of serum-independent polymorphonuclear leukocyte chemotactic factors produced by Propionibacterium acnes. Inflammation (1980) 1.14
The chemoattractant properties of comedonal components. J Invest Dermatol (1978) 1.10
A sensitive assay method for peroxidases from various sources. J Reticuloendothel Soc (1978) 1.06
Radiolabelling of Corynebacterium parvum and its distribution in mice. Br J Cancer (1977) 1.05
Polymorphonuclear leukocyte lysosomal release in response to Propionibacterium acnes in vitro and its enhancement by sera from inflammatory acne patients. J Invest Dermatol (1980) 0.96
The effect of leukocyte hydrolases on bacteria. III. Bacteriolysis induced by extracts of different leukocyte populations and the inhibition of lysis by macromolecular substances. J Infect Dis (1975) 0.93
Activation of the alternative pathway of complement in human serum by Propionibacterium acnes (Corynebacterium parvum) cell fractions. Inflammation (1981) 0.90
Fate of vaccines of Propionibacterium acnes after phagocytosis by murine macrophages. Infect Immun (1982) 0.87
Organ distribution of Corynebacterium parvum labeled with iodine-125. J Natl Cancer Inst (1977) 0.81
Studies on lysosomes. XI. Characterization of a hydrolase-rich fraction from human lymphocytes. J Cell Biol (1968) 4.22
Human lymphocyte-sheep erythrocyte rosette formation: some characteristics of the interaction. Clin Immunol Immunopathol (1973) 3.55
Localization of A antigen sites on human erythrocyte ghosts. Nature (1971) 2.99
Purification of human monocytes on microexudate-coated surfaces. J Immunol (1978) 2.86
The key role of peptidoglycan in the opsonization of Staphylococcus aureus. J Clin Invest (1978) 2.83
Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin. J Am Acad Dermatol (2001) 2.80
Studies on human peripheral blood lymphocytes in vitro. II. Morphological and biochemical studies on the transformation of lymphocytes by pokeweed mitogen. J Exp Med (1966) 2.63
Development of functional complement receptors during in vitro maturation of human monocytes into macrophages. J Immunol (1980) 2.47
The IgG receptor: an immunological marker for the characterization of mononuclear cells. Immunology (1969) 2.46
Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol (1974) 2.43
Sheep red cell binding to human lymphocytes treated with neuraminidase; enhancement of T cell binding and identification of a subpopulation of B cells. J Exp Med (1973) 2.37
Studies on human peripheral blood lymphocytes in vitro. I. Biological and physicochemical properties of the pokeweed mitogen. J Exp Med (1966) 2.27
Purification of human monocytes on gelatin-coated surfaces. J Immunol Methods (1986) 2.16
Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia. Br J Dermatol (2001) 2.14
Human monocytes and macrophages express substance P and neurokinin-1 receptor. J Immunol (1997) 2.08
Human lymphocyte response to phytomitogens in vitro: normal, agammaglobulinemic and paraproteinemic individuals. J Immunol (1969) 2.05
Studies on human peripheral blood lymphocytes in vitro. 3. Fine structural features of lymphocyte transformation by pokeweed mitogen. J Immunol (1967) 2.03
Regional variations of cutaneous propionibacteria. Appl Environ Microbiol (1978) 2.00
Intracellular levels and stimulated release of lysosomal enzymes from human peripheral blood monocytes and monocyte-derived macrophages. J Reticuloendothel Soc (1980) 1.85
Myasthenia gravis. Lancet (1966) 1.82
The microbiology of the human axilla and its relationship to axillary odor. J Invest Dermatol (1981) 1.82
Analyses of volatile organic compounds from human skin. Br J Dermatol (2008) 1.82
Roaccutane treatment guidelines: results of an international survey. Dermatology (1997) 1.70
Leukocytosis and natural killer cell function parallel neurobehavioral fatigue induced by 64 hours of sleep deprivation. J Clin Invest (1994) 1.70
Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol (1983) 1.67
Topical tretinoin for photoaged skin. J Am Acad Dermatol (1986) 1.67
Macrophage-tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor. J Virol (1990) 1.65
Human serum induces maturation of human monocytes in vitro. Changes in cytolytic activity, intracellular lysosomal enzymes, and nonspecific esterase activity. Am J Pathol (1983) 1.65
Photoaging/photodamage and photoprotection. J Am Acad Dermatol (1990) 1.63
A non-x-linked syndrome with susceptibility to severe Epstein-Barr virus infections. J Pediatr (1982) 1.60
Disappearance and recovery of human monocyte IgG receptor activity after phagocytosis. J Immunol (1972) 1.59
Marrow transplantation in chronic granulomatous disease: an update, with 6-year follow-up. J Pediatr (1988) 1.57
Long-term human peripheral blood monocyte cultures: establishment, metabolism and morphology of primary human monocyte-macrophage cell cultures. Immunology (1979) 1.55
IgG subclass specificity of human monocyte receptor sites. Nature (1971) 1.55
Granulocytopathies: pleomorphism of neutrophil dysfunction. Am J Med (1969) 1.54
Electron microscopic and functional aspects of human lymphocyte response to mitogens. Transplant Rev (1972) 1.54
Modulation of neutrophil function by lysozyme. Potential negative feedback system of inflammation. J Clin Invest (1979) 1.54
Human lymphocytes express substance P and its receptor. J Neuroimmunol (1998) 1.52
Physiologic, microbiologic, and seasonal effects of handwashing on the skin of health care personnel. Am J Infect Control (1986) 1.51
Clinical, serologic and leukocyte function studies on patients with idiopathic "acquired" agammaglobulinemia and their families. Am J Med (1970) 1.50
Staphylococcal IgE antibodies, hyperimmunoglobulinemia E and Staphylococcus aureus infections. N Engl J Med (1979) 1.47
Human lymphocyte growth in vitro: morphologic, biochemical, and immunologic significance. Int Rev Exp Pathol (1971) 1.45
A defect in circulating mononuclear phagocytes in chronicgranulomatous disease of childhood. J Immunol (1968) 1.44
Age-related changes in the resident bacterial flora of the human face. J Invest Dermatol (1975) 1.41
Acne fulminans: investigation of acute febrile ulcerative acne. Arch Dermatol (1977) 1.39
Pathophysiological effects of Vibrio cholerae and enterotoxigenic Escherichia coli and their exotoxins on eucaryotic cells. Microbiol Rev (1978) 1.39
Pathogenic JK group corynebacteria and their similarity to human cutaneous lipophilic diphtheroids. J Infect Dis (1985) 1.38
Adverse effects of fluorinated steroids applied to the face. JAMA (1974) 1.38
Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect Immun (1995) 1.37
Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes. Proc Natl Acad Sci U S A (2001) 1.36
Infection of cord blood monocyte-derived macrophages with human immunodeficiency virus type 1. J Virol (1992) 1.36
Bacteriology. J Invest Dermatol (1976) 1.35
Propionibacterium levels in patients with and without acne vulgaris. J Invest Dermatol (1975) 1.35
Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency. Blood (1992) 1.34
In vitro development of plasma cells from lymphocytes following pokeweed mitogen stimulation: a fine structural study. Exp Cell Res (1969) 1.34
Skin microflora. J Invest Dermatol (1987) 1.33
Role of microorganisms in dandruff. Arch Dermatol (1976) 1.32
Contact regions for dinitrophenyl and menadione haptens in an immunoglobulin binding more than one antigen. Proc Natl Acad Sci U S A (1972) 1.32
Quantitative microbiology of the scalp in non-dandruff, dandruff, and seborrheic dermatitis. J Invest Dermatol (1975) 1.32
Epithelioid angiomatosis: a distinct vascular disorder in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Lancet (1987) 1.30
Development of the premature infant's host defense system and its relationship to routine immunizations. Clin Perinatol (1984) 1.27
Isolation of highly purified human blood monocytes for in vitro HIV-1 infection studies of monocyte/macrophages. J Immunol Methods (1990) 1.27
Dynamics of the macrophage plasma membrane. Annu Rev Microbiol (1979) 1.26
Association of Pseudomonas cepacia with chronic granulomatous disease. J Clin Microbiol (1975) 1.25
Protective role of beta-chemokines associated with HIV-specific Th responses against perinatal HIV transmission. J Immunol (1999) 1.24
Regional variations in density of cutaneous propionibacteria: correlation of Propionibacterium acnes populations with sebaceous secretion. J Clin Microbiol (1980) 1.24
Receptor sites on human monocytes for complement: binding of red cells sensitized by cold autoantibodies. Br J Haematol (1970) 1.23
Skin colonization with antibiotic-resistant (JK group) and antibiotic-sensitive lipophilic diphtheroids in hospitalized and normal adults. J Infect Dis (1986) 1.23
Placental transfer of immunoglobulin G subclasses. Clin Diagn Lab Immunol (1994) 1.23
Report of the Consensus Conference on Acne Classification. Washington, D.C., March 24 and 25, 1990. J Am Acad Dermatol (1991) 1.22
Microbial flora on the hands of health care personnel: differences in composition and antibacterial resistance. Infect Control Hosp Epidemiol (1988) 1.22
T-cell subpopulations in chronic lymphocytic leukemia: abnormalities in distribtuion and in in vitro receptor maturation. Blood (1979) 1.22
Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections. Am Rev Respir Dis (1990) 1.21
Humoral and formed elements of blood modulate the response of peripheral blood monocytes. I. Plasma and serum inhibit and platelets enhance monocyte adherence. J Immunol (1979) 1.20
Serum levels of substance P are elevated in patients with sickle cell disease and increase further during vaso-occlusive crisis. Blood (1998) 1.20
Use of bacteriophage typing to distinguish Propionibacterium acne types I and II. J Clin Microbiol (1978) 1.19
Isotretinoin treatment of acne and related disorders: an update. J Am Acad Dermatol (1983) 1.19
NHLBI Workshop Summary. Pharmacological therapy for idiopathic pulmonary fibrosis. Past, present, and future. Am J Respir Crit Care Med (1999) 1.18
Cytokine profile in genital tract secretions from female adolescents: impact of human immunodeficiency virus, human papillomavirus, and other sexually transmitted pathogens. J Infect Dis (2000) 1.18
Analytic review: disorders of phagocyte function. Blood (1970) 1.18
Effects of levamisole on human monocyte function and immunoprotein receptors. Clin Immunol Immunopathol (1976) 1.17
Headspace analysis of volatile metabolites of Pseudomonas aeruginosa and related species by gas chromatography-mass spectrometry. J Clin Microbiol (1980) 1.17
Full-length and truncated neurokinin-1 receptor expression and function during monocyte/macrophage differentiation. Proc Natl Acad Sci U S A (2006) 1.17
Complement activation in acne vulgaris: in vitro studies with Propionibacterium acnes and Propionibacterium granulosum. Infect Immun (1978) 1.16
Urinary ammonia and ammonia-producing microorganisms in infants with and without diaper dermatitis. Arch Dermatol (1977) 1.16
Absorption of minocycline hydrochloride and tetracycline hydrochloride. Effect of food, milk, and iron. J Am Acad Dermatol (1985) 1.15
A genetic defect in "acquired" agammaglobulinemia. Proc Natl Acad Sci U S A (1968) 1.15
Physiologic and microbiologic changes in skin related to frequent handwashing. Infect Control (1986) 1.15
Characterization of serum-independent polymorphonuclear leukocyte chemotactic factors produced by Propionibacterium acnes. Inflammation (1980) 1.14
Expression of the complement receptors CR1 and CR3 and the type III Fc gamma receptor on neutrophils from newborn infants and from fetuses with Rh disease. Pediatr Res (1990) 1.12